Related Experiment Video
Updated: Jul 15, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Haemophilia A: molecular insights.
Giuseppe Castaldo1, Valeria D'Argenio, Paola Nardiello
1Dipartimento di Biochimica e Biotecnologie Mediche, Università di Napoli Federico II, CEINGE-Biotecnologie avanzate and SEMM, Naples, Italy. castaldo@dbbm.unina.it
Haemophilia A, a bleeding disorder from F8C gene defects, affects 1:5000 males. Molecular diagnostics identify carriers and enable prenatal testing, crucial for understanding disease variants.
Area of Science:
- Genetics
- Hematology
- Molecular Biology
Background:
- Haemophilia A is the most common inherited bleeding disorder, caused by F8C gene mutations.
- It is an X-linked recessive disorder affecting approximately 1 in 5000 males.
- Diagnosis involves assessing coagulation times and factor VIII activity.
Purpose of the Study:
- To detail molecular diagnostic approaches for Haemophilia A.
- To identify common F8C gene mutations like intron 22 and 1 inversions.
- To explore the influence of prothrombotic gene variants on Haemophilia A clinical expression.
Main Methods:
- Molecular analysis including gene sequencing and scanning techniques.
- Linkage analysis using DNA polymorphic markers for mutation identification.
- Investigation of genotype-phenotype correlations by examining prothrombotic gene variants.
Main Results:
- Intron 22 and 1 inversions account for ~55% of Haemophilia A cases.
- Large gene deletions and point mutations/small insertions/deletions constitute the remaining cases.
- Research is ongoing into how prothrombotic gene variants modify disease severity.
Conclusions:
- Molecular diagnostics are essential for Haemophilia A carrier and prenatal testing.
- Identifying specific F8C mutations aids in understanding disease mechanisms.
- Further research is needed to clarify the role of genetic modifiers in Haemophilia A.
More Related Videos
09:35Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
08:01The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...